Inicio > BIGG > Resultado de la búsqueda

    Resultados: 2

    Non-alcoholic fatty liver disease (NAFLD): assessment and management

    England. National Institute for Health and Care Excellence.
    This guideline covers how to identify the adults, young people and children with non-alcoholic fatty liver disease (NAFLD) who have advanced liver fibrosis and are most at risk of further complications. It outlines the lifestyle changes and pharmacological treatments that can manage NAFLD and advanced li...
    Enfermedad del Hígado Graso no Alcohólico/terapia, Enfermedad del Hígado Graso no Alcohólico/tratamiento farmacológico, Enfermedad del Hígado Graso no Alcohólico/diagnóstico, Pioglitazona/uso terapéutico, Vitamina E/uso terapéutico, Cirrosis Hepática/prevención & control, Síndrome Metabólico/prevención & control
    Texto completo

    Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

    Watanabe, S; Hashimoto, E; Ikejima, K; Uto, H; Ono, M; Sumida, Y; Seike, M; Takei, Y; Takehara, T; Tokushige, K; Nakajima, A; Yoneda, M; Saibara, T; Shiota, G; Sakaida, I; Nakamuta, M; Mizuta, T; Tsubouchi, H; Sugano, K; Shimosegawa, T.
    J. Gastroenterol; 50 (4), 2015
    Nonalcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver disease in industrialized countries worldwide, and has become a serious public health issue not only in Western countries but also in many Asian countries including Japan. Within the wide spectrum of NAFLD, nonal...
    Enfermedad del Hígado Graso no Alcohólico/tratamiento farmacológico, Tiazolidinedionas/uso terapéutico, Vitamina E/uso terapéutico, Cirugía Bariátrica, Trasplante de Hígado
    Texto completo